Leonardo DRS: 22% Stock Price Drop Supports Strong Buy Rating (Upgrade)

Leonardo DRS shares have fallen about 22% since a prior downgrade, well behind the S&P 500’s 14.1% gain, and the pullback has prompted an upgrade to Strong Buy as an attractive entry point. The company reported strong Q3 revenue growth and backlog expansion but is seeing near-term margin pressure from higher germanium costs and ramping R&D, and management has tightened guidance to 10–11% revenue growth with flat EBITDA. Analysts highlight double‑digit CAGR potential driven by defense demand and model 19–42% upside to price targets, framing this as a longer‑term value opportunity despite short‑term margin headwinds.

Analysis

Leonardo DRS shares have declined roughly 22.3% since the prior downgrade, materially underperforming the S&P 500’s 14.1% gain; the author has upgraded the name to Strong Buy after a roughly 22% pullback and frames this as an attractive entry point. The upgrade is grounded in the company’s reported strong Q3 revenue growth and backlog expansion, which support near‑term demand visibility in defense end markets.

Management tightened guidance to 10–11% revenue growth with stable EBITDA, signaling cautious optimism: revenue momentum is intact but near‑term margin pressure is evident from higher germanium input costs and an R&D ramp. Those margin headwinds explain the tightened outlook and imply that profitability improvements may lag revenue growth in the next few quarters.

Analysts cited double‑digit CAGR potential and project 19–42% upside to price targets, suggesting favorable medium‑term upside if backlog converts and commodity costs normalize. Key risks are persistent germanium inflation, continued R&D investment compressing margins, and execution against the tightened guidance; sentiment metrics are moderately positive but market impact appears modest.

Key Decisions for Investors

• Consider initiating a modest long position on the pullback given the 22% decline and 19–42% analyst price target upside, while sizing exposure to reflect near‑term margin risk
• Monitor quarterly updates for germanium cost trends, R&D spending cadence and EBITDA trajectory and be prepared to trim or hedge if margin guidance deteriorates further
• If already invested, hold and reassess on evidence of backlog conversion into higher‑margin revenue or clearer commodity cost relief, otherwise consider reducing exposure